NO20005670L - Proteiner fra Moraxella Catarrhalis - Google Patents

Proteiner fra Moraxella Catarrhalis

Info

Publication number
NO20005670L
NO20005670L NO20005670A NO20005670A NO20005670L NO 20005670 L NO20005670 L NO 20005670L NO 20005670 A NO20005670 A NO 20005670A NO 20005670 A NO20005670 A NO 20005670A NO 20005670 L NO20005670 L NO 20005670L
Authority
NO
Norway
Prior art keywords
proteins
moraxella catarrhalis
catarrhalis
moraxella
vaccines
Prior art date
Application number
NO20005670A
Other languages
English (en)
Norwegian (no)
Other versions
NO20005670D0 (no
Inventor
Allan William Cripps
Jennelle Kyd
Original Assignee
Provalis Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Provalis Uk Ltd filed Critical Provalis Uk Ltd
Publication of NO20005670D0 publication Critical patent/NO20005670D0/no
Publication of NO20005670L publication Critical patent/NO20005670L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20005670A 1998-05-11 2000-11-10 Proteiner fra Moraxella Catarrhalis NO20005670L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9810084.5A GB9810084D0 (en) 1998-05-11 1998-05-11 Proteins
PCT/GB1999/001473 WO1999058563A2 (en) 1998-05-11 1999-05-11 Moraxella catharralis proteins

Publications (2)

Publication Number Publication Date
NO20005670D0 NO20005670D0 (no) 2000-11-10
NO20005670L true NO20005670L (no) 2001-01-10

Family

ID=10831854

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005670A NO20005670L (no) 1998-05-11 2000-11-10 Proteiner fra Moraxella Catarrhalis

Country Status (20)

Country Link
US (2) US7557185B2 (de)
EP (2) EP1849800A3 (de)
JP (1) JP4782281B2 (de)
KR (1) KR20010071236A (de)
CN (2) CN101684147A (de)
AT (1) ATE355301T1 (de)
AU (1) AU769020B2 (de)
CA (1) CA2328130A1 (de)
CY (1) CY1107636T1 (de)
DE (1) DE69935323T2 (de)
DK (1) DK1077999T3 (de)
ES (1) ES2284254T3 (de)
GB (1) GB9810084D0 (de)
IL (1) IL139495A0 (de)
NO (1) NO20005670L (de)
NZ (3) NZ537460A (de)
PT (1) PT1077999E (de)
RU (1) RU2000131225A (de)
WO (1) WO1999058563A2 (de)
ZA (1) ZA200006489B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810084D0 (en) * 1998-05-11 1998-07-08 Cortecs Uk Ltd Proteins
US6541616B1 (en) * 1998-10-01 2003-04-01 Antex Biologics Inc. Moraxella catarrhalis protein, gene sequence and uses thereof
EP1185658B1 (de) * 1999-05-24 2008-06-04 GlaxoSmithKline Biologicals S.A. Neue verbindungen aus moraxella catarrhalis
US7410645B2 (en) 2001-05-15 2008-08-12 Id Biomedical Corporation Moraxella (Branhamella) catarrhalis antigens
DE60229871D1 (de) 2001-11-16 2008-12-24 Id Biomedical Corp Moraxella (branhamella) catarrhalis polypeptide
EP2074142A4 (de) * 2006-10-19 2010-10-27 Angiochem Inc Verbindungen zur stimulierung der funktion von p-glykoprotein und anwendungen davon

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292869A (en) 1989-04-27 1994-03-08 The Board Of Governors Of The University Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same
US5552146A (en) 1991-08-15 1996-09-03 Board Of Regents, The University Of Texas System Methods and compositions relating to useful antigens of Moraxella catarrhalis
US5993826A (en) * 1993-03-02 1999-11-30 Board Of Regents, The University Of Texas Methods and compositions relating to useful antigens of moraxella catarrhalis
US5712118A (en) * 1993-09-29 1998-01-27 Research Foundation Of State University Of New York Vaccine for branhamella catarrhalis
US5607846A (en) * 1994-05-17 1997-03-04 Research Foundation Of State University Of New York Vaccine for moraxella catarrhalis
US6121427A (en) * 1994-10-24 2000-09-19 Connaught Laboratories Limited Major outer membrane protein CD of branhamella
US6090576A (en) * 1996-03-08 2000-07-18 Connaught Laboratories Limited DNA encoding a transferrin receptor of Moraxella
US7341727B1 (en) 1996-05-03 2008-03-11 Emergent Product Development Gaithersburg Inc. M. catarrhalis outer membrane protein-106 polypeptide, methods of eliciting an immune response comprising same
US6004562A (en) * 1996-08-16 1999-12-21 The Research Foundation Of The State University Of New York Outer membrane protein B1 of Moraxella catarrhalis
GB9810084D0 (en) * 1998-05-11 1998-07-08 Cortecs Uk Ltd Proteins
US6541616B1 (en) 1998-10-01 2003-04-01 Antex Biologics Inc. Moraxella catarrhalis protein, gene sequence and uses thereof
EP1185658B1 (de) 1999-05-24 2008-06-04 GlaxoSmithKline Biologicals S.A. Neue verbindungen aus moraxella catarrhalis

Also Published As

Publication number Publication date
IL139495A0 (en) 2001-11-25
EP1077999B1 (de) 2007-02-28
AU3838399A (en) 1999-11-29
US7557185B2 (en) 2009-07-07
ZA200006489B (en) 2002-08-12
CN1306542A (zh) 2001-08-01
CA2328130A1 (en) 1999-11-18
NO20005670D0 (no) 2000-11-10
EP1849800A2 (de) 2007-10-31
NZ528725A (en) 2005-02-25
DE69935323T2 (de) 2008-01-17
ATE355301T1 (de) 2006-03-15
CN101684147A (zh) 2010-03-31
CY1107636T1 (el) 2013-04-18
ES2284254T3 (es) 2007-11-01
PT1077999E (pt) 2007-06-06
WO1999058563A2 (en) 1999-11-18
JP2002514657A (ja) 2002-05-21
EP1077999A2 (de) 2001-02-28
NZ508004A (en) 2003-11-28
GB9810084D0 (en) 1998-07-08
US20090246228A1 (en) 2009-10-01
DE69935323D1 (de) 2007-04-12
US20040005328A1 (en) 2004-01-08
NZ537460A (en) 2005-12-23
DK1077999T3 (da) 2007-05-29
AU769020B2 (en) 2004-01-15
EP1849800A3 (de) 2007-12-05
WO1999058563A3 (en) 1999-12-29
RU2000131225A (ru) 2003-05-27
KR20010071236A (ko) 2001-07-28
JP4782281B2 (ja) 2011-09-28

Similar Documents

Publication Publication Date Title
CY1114722T1 (el) Αντιγονα στρεπτοκοκκου
ITTO950367A0 (it) Proteine di prrsv ricombinanti, corredi diagnostici e vaccini contenenti tali proteine di prrsv ricombinanti.
EA200300464A1 (ru) ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ
FI913560A7 (fi) Synteettiset peptidit, erikoisesti HCV:n vasta-aineiden havaitsemiseen, HCV infektion diagnoosiin ja sen estämiseen rokotteina
CY1107447T1 (el) Ετερολογη εκφραση πρωτεϊνων των neisseria
ATE337399T1 (de) Zusammensetzungen zur immuntherapie und diagnose von tuberculosis
ATE229978T1 (de) Helicobacter proteine und impstoffe
ATE361365T1 (de) Streptococcus pneumoniae proteine und nukleinsäuren
DK1181319T3 (da) Kimære DR4-antistoffer og anvendelser deraf
DK1542732T3 (da) Fusionsproteiner af Mycobacterium tuberculosis
DK0821693T3 (da) Nye DNA-sekvenser fra human cytomegalovirus (HCMV)
CY1107636T1 (el) Πρωτεϊνες moraxella catarrhalis
ATE530572T1 (de) Antigen-cocktails, p35 und verwendungen dafür
ATE171473T1 (de) Humanisierte monoklonale antikörper gegen humanes interleukin - 4
NO913814D0 (no) Innskudd av dna med modifiserte transposoner.
DE69728897D1 (de) Saeugetierchemokine
CY1106349T1 (el) Συστηματα ανιχνευσης ανοσοπροσδιορισμου ιικου αντιγονου ηπατιτιδας c
ES2236703T3 (es) Uso de metodos para identificar oligopeptidos de señal hidrofilos.
DK0491713T3 (da) Rubella El-peptider og C-peptider
ATE332712T1 (de) Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe
DE3482924D1 (de) Reagenz zur verwendung im nachweis des antikoerpers gegen menschliche t-zellen-leukemievirusantigene.
DE69232975D1 (de) Protein p100von menschlichem Herpesvirus Typ 6, die korrespondierenden DNS Squenzen, ihre Herstellung und Verwendung
DK0809653T3 (da) Helicobacter pylori-antigen
FI970299A0 (fi) Oligomeeriset kantajamolekyylit, joissa on määritetysti sisällytettyjä merkitsinryhmiä ja hapteeneja
CY1108864T1 (el) Ενωσεις για ανοσοθεραπεια και διαγνωση φυματιωσης και μεθοδοι χρησεις τους

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application